FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sylvie Chalon

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Activities & Behaviors

Animal Behavior

Co-author Network

Publications

TOP 3
Claire Tronel; Nicolas Arlicot; Sylvie Bodard; Sylvie Chalon; Gael Rochefort; Daniel Antier
Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model.
Serge Maia; Jackie Vergote; Emilie Vierron; Nicolas Arlicot; Sylvie Bodard; Denis Guilloteau; Sylvie Chalon
Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
Rai Khalid Farooq; Elsa Isingrini; Anne Marie le Guisquet; Samuel Leman; Frederic Minier; Arnaud Tanti; Nicolas Arlicot; Catherine Belzung; Sylvie Chalon; Vincent Camus
Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sylvie Chalon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claire Tronel; Nicolas Arlicot; Sylvie Bodard; Sylvie Chalon; Gael Rochefort; Daniel Antier
Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model.
Oxidative medicine and cellular longevity 2013;2013():264935.
2012: Serge Maia; Jackie Vergote; Emilie Vierron; Nicolas Arlicot; Sylvie Bodard; Denis Guilloteau; Sylvie Chalon
Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.
Synapse (New York, N.Y.) 2012;66(7):573-83.
2012: Rai Khalid Farooq; Elsa Isingrini; Anne Marie le Guisquet; Samuel Leman; Frederic Minier; Arnaud Tanti; Nicolas Arlicot; Catherine Belzung; Sylvie Chalon; Vincent Camus
Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
Behavioural brain research 2012;231(1):130-7.
2012: Katherine R Leaver; Aaron Reynolds; Sylvie Bodard; Sylvie Chalon; Denis Guilloteau; Michael Kassiou
Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum.
ACS chemical neuroscience 2012;3(2):114-9.
2011: Diane Dufour-Rainfray; Patrick Vourc'h; Sébastien Tourlet; Denis Guilloteau; Sylvie Chalon; Christian R Andres
Fetal exposure to teratogens: evidence of genes involved in autism.
Neuroscience and biobehavioral reviews 2011;35(5):1254-65.
2010: Nicolas Arlicot; Edwige Petit; Andrew Katsifis; Jérôme Toutain; Didier Divoux; Sylvie Bodard; Simon Roussel; Denis Guilloteau; Myriam Bernaudin; Sylvie Chalon
Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE.
European journal of nuclear medicine and molecular imaging 2010;37(12):2371-80.
2010: Pu-Jiao Song; Céline Barc; Nicolas Arlicot; Denis Guilloteau; Serge Bernard; Pierre Sarradin; Sylvie Chalon; Lucette Garreau; Hank F Kung; Frédéric Lantier; Jackie Vergote
Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2010;12(6):576-82.
2010: Emilie Heuland; Marie-Aure Germaux; Laurent Galineau; Sylvie Chalon; Catherine Belzung
Prenatal MDMA exposure delays postnatal development in the rat: a preliminary study.
Neurotoxicology and teratology 2010;32(4):425-31.
2010: Emmanuelle Lagrue; Hiroyuki Abe; Madakasira Lavanya; Jawida Touhami; Sylvie Bodard; Sylvie Chalon; Jean-Luc Battini; Marc Sitbon; Pierre Castelnau
Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport.
Journal of biomedical science 2010;17():91.
2009: Sylvie Chalon
The role of fatty acids in the treatment of ADHD.
Neuropharmacology 2009;57(7-8):636-9.
2008: Ipek Yalcin; Stéphanie Coubard; Sylvie Bodard; Sylvie Chalon; Catherine Belzung
Effects of 5,7-dihydroxytryptamine lesion of the dorsal raphe nucleus on the antidepressant-like action of tramadol in the unpredictable chronic mild stress in mice.
Psychopharmacology 2008;200(4):497-507.
2008: Catherine I Rousset; Jinane Kassem; Paul Olivier; Sylvie Chalon; Pierre Gressens; Elie Saliba
Antenatal bacterial endotoxin sensitizes the immature rat brain to postnatal excitotoxic injury.
Journal of neuropathology and experimental neurology 2008;67(10):994-1000.
2008: Sylvie Mavel; Johnny Vercouillie; Lucette Garreau; Tiziana Raguza; Aina Westrheim Ravna; Sylvie Chalon; Denis Guilloteau; Patrick Emond
Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
Bioorganic & medicinal chemistry 2008;16(19):9050-5.
2008: Alexandre Surget; Michael Saxe; Samuel Leman; Yadira Ibarguen-Vargas; Sylvie Chalon; Guy Griebel; René Hen; Catherine Belzung
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
Biological psychiatry 2008;64(4):293-301.
2008: Gaëlle Bouchez; Luc Sensebé; Patrick Vourc'h; Lucette Garreau; Sylvie Bodard; Angélique Rico; Denis Guilloteau; Pierre Charbord; Jean-Claude Besnard; Sylvie Chalon
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Neurochemistry international 2008;52(7):1332-42.
2008: Michelle L James; Roger R Fulton; Johnny Vercoullie; David J Henderson; Lucette Garreau; Sylvie Chalon; Frederic Dolle; Barbara Costa; Silvia Selleri; Denis Guilloteau; Michael Kassiou
DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(5):814-22.
2008: Pu-Jiao Song; Serge Bernard; Pierre Sarradin; Jackie Vergote; Céline Barc; Sylvie Chalon; Mei-Ping Kung; Hank F Kung; Denis Guilloteau
IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
Nuclear medicine and biology 2008;35(2):197-201.
2008: Sylvie Vancassel; Samuel Leman; L Hanonick; S Denis; J Roger; Mathieu Nollet; Sylvie Bodard; I Kousignian; C Belzung; Sylvie Chalon
n-3 polyunsaturated fatty acid supplementation reverses stress-induced modifications on brain monoamine levels in mice.
Journal of lipid research 2008;49(2):340-8.
2008: Patrick Emond; Denis Guilloteau; Sylvie Chalon
PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.
CNS neuroscience & therapeutics 2008;14(1):47-64.
2008: Satish K Chitneni; Lucette Garreau; Bernard J Cleynhens; Nele Evens; Marva Bex; Peter Vermaelen; Sylvie Chalon; Roger Busson; Denis Guilloteau; Koen Van Laere; Alfons Verbruggen; Guy Bormans
Improved synthesis and metabolic stability analysis of the dopamine transporter ligand [(18)F]FECT.
Nuclear medicine and biology 2008;35(1):75-82.
2007: Nicolas Giboureau; Patrick Emond; Roger R Fulton; David J Henderson; Sylvie Chalon; Lucette Garreau; Peter Roselt; Stefan Eberl; Sylvie Mavel; Sylvie Bodard; Michael J Fulham; Denis Guilloteau; Michael Kassiou
Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter.
Synapse (New York, N.Y.) 2007;61(12):962-70.
2007: Patrick Emond; Sylvie Mavel; Yolanda Zea-Ponce; Michael Kassiou; Lucette Garreau; Sylvie Bodard; Marie-Laure Drossard; Sylvie Chalon; Denis Guilloteau
(E)-[125I]-5-AOIBV: a SPECT radioligand for the vesicular acetylcholine transporter.
Nuclear medicine and biology 2007;34(8):967-71.
2007: Ipek Yalcin; Fazilet Aksu; Sylvie Bodard; Sylvie Chalon; Catherine Belzung
Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system.
Behavioural pharmacology 2007;18(7):623-31.
2007: Emmanuelle Lagrue; Sylvie Chalon; Sylvie Bodard; Elie Saliba; Pierre Gressens; Pierre Castelnau
Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice.
Pediatric research 2007;62(1):14-9.
2007: Mitchell Quinlivan; Sylvie Chalon; Jackie Vergote; Jasmine Henderson; Andrew Katsifis; Michael Kassiou; Denis Guilloteau
Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning.
Neuroscience letters 2007;415(2):97-101.
2007: Wadad Saba; Héric Valette; Marie-Anne Schöllhorn-Peyronneau; Christine Coulon; Michèle Ottaviani; Sylvie Chalon; Frederic Dolle; Patrick Emond; Christer Halldin; Julie Helfenbein; Jean-Claude Madelmont; Jean-Bernard Deloye; Denis Guilloteau; Michel Bottlaender
[11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.
Synapse (New York, N.Y.) 2007;61(1):17-23.
2006: Thaer Assaad; Sylvie Mavel; Stanley M Parsons; Shane Kruse; Laurent Galineau; Hassan Allouchi; Michael Kassiou; Sylvie Chalon; Denis Guilloteau; Patrick Emond
Synthesis and in vitro evaluation of N-substituted aza-trozamicol analogs as vesicular acetylcholine transporter ligands.
Bioorganic & medicinal chemistry letters 2006;16(10):2654-7.
2006: Sylvie Chalon; Håkan Hall; Wadad Saba; Lucette Garreau; Frédéric Dollé; Christer Halldin; Patrick Emond; Michel Bottlaender; Jean-Bernard Deloye; Julie Helfenbein; Jean-Claude Madelmont; Sylvie Bodard; Zoïa Mincheva; Jean-Claude Besnard; Denis Guilloteau
Pharmacological characterization of (E)-N-(4-fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a highly promising fluorinated ligand for the dopamine transporter.
The Journal of pharmacology and experimental therapeutics 2006;317(1):147-52.
2006: Catherine I Rousset; Sylvie Chalon; Sylvain Cantagrel; Sylvie Bodard; Christian Andres; Pierre Gressens; Elie Saliba
Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats.
Pediatric research 2006;59(3):428-33.
2006: Johnny Vercouillie; Sylvie Mavel; Laurent Galineau; Tiziana Ragusa; Robert Innis; Michael Kassiou; Sylvie Chalon; Frédéric Dollé; Jean-Claude Besnard; Denis Guilloteau; Patrick Emond
Synthesis and in vitro evaluation of novel derivatives of diphenylsulfide as serotonin transporter ligands.
Bioorganic & medicinal chemistry letters 2006;16(5):1297-300.
2006: Frédéric Dollé; Patrick Emond; Sylvie Mavel; Stéphane Demphel; Françoise Hinnen; Zoïa Mincheva; Wadad Saba; Héric Valette; Sylvie Chalon; Christer Halldin; Julie Helfenbein; Joël Legaillard; Jean-Claude Madelmont; Jean-Bernard Deloye; Michel Bottlaender; Denis Guilloteau
Synthesis, radiosynthesis and in vivo preliminary evaluation of [11C]LBT-999, a selective radioligand for the visualisation of the dopamine transporter with PET.
Bioorganic & medicinal chemistry 2006;14(4):1115-25.
2005: Christer Halldin; Johan Lundberg; Judit Sóvágó; Balázs Gulyás; Denis Guilloteau; Johnny Vercouillie; Patrick Emond; Sylvie Chalon; Jari Tarkiainen; Jukka Hiltunen; Lars Farde
[(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Synapse (New York, N.Y.) 2005;58(3):173-83.
2005: Sylvie Vancassel; Sabah Aïd; Fabien Pifferi; Elise Morice; Marika Nosten-Bertrand; Sylvie Chalon; Monique Lavialle
Cerebral asymmetry and behavioral lateralization in rats chronically lacking n-3 polyunsaturated fatty acids.
Biological psychiatry 2005;58(10):805-11.
2005: Gweltas Mauger; Wadad Saba; Philippe Hantraye; Frederic Dolle; Christine Coulon; Yann Bramoullé; Sylvie Chalon; Marie-Claude Grégoire
Multiinjection approach for D2 receptor binding quantification in living rats using [11C]raclopride and the beta-microprobe: crossvalidation with in vitro binding data.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2005;25(11):1517-27.
2005: Laurent Galineau; Catherine Belzung; Ercem Kodas; Sylvie Bodard; Denis Guilloteau; Sylvie Chalon
Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Brain research. Developmental brain research 2005;154(2):165-76.
2005: Yolanda Zea-Ponce; Sylvie Mavel; Thaer Assaad; Shane E Kruse; Stanley M Parsons; Patrick Emond; Sylvie Chalon; Nicolas Giboureau; Michael Kassiou; Denis Guilloteau
Synthesis and in vitro evaluation of new benzovesamicol analogues as potential imaging probes for the vesicular acetylcholine transporter.
Bioorganic & medicinal chemistry 2005;13(3):745-53.
2005: Denis Guilloteau; Sylvie Chalon
PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders.
Current pharmaceutical design 2005;11(25):3237-45.
2004: Laurent Galineau; Ercem Kodas; Denis Guilloteau; Marie-Paule Vilar; Sylvie Chalon
Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study.
Neuroscience letters 2004;363(3):266-71.
2004: Ercem Kodas; Laurent Galineau; Sylvie Bodard; Sylvie Vancassel; Denis Guilloteau; Jean-Claude Besnard; Sylvie Chalon
Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.
Journal of neurochemistry 2004;89(3):695-702.
2004: Sylvie Chalon; Cécile Bronquard; Johnny Vercouillie; Ercem Kodas; Lucette Garreau; Sylvie Bodard; Patrick Emond; Jean-Claude Besnard; Denis Guilloteau
ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models.
Synapse (New York, N.Y.) 2004;52(2):136-42.
2004: Paula Ravenscroft; Sylvie Chalon; Jonathan M Brotchie; Alan R Crossman
Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
Experimental neurology 2004;185(1):36-46.
2003: Wassilios Meissner; Caroline Prunier; Denis Guilloteau; Sylvie Chalon; Christian E Gross; Erwan Bezard
Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.
Molecular neurobiology 2003;28(3):209-18.
2003: Mitchell Quinlivan; Filomena Mattner; Vahan Papazian; Jia Zhou; Andrew Katsifis; Patrick Emond; Sylvie Chalon; Alan P Kozikowski; Denis Guilloteau; Michael Kassiou
Synthesis and evaluation of iodine-123 labelled tricyclic tropanes as radioligands for the serotonin transporter.
Nuclear medicine and biology 2003;30(7):741-6.
2003: Sylvain Cantagrel; Catherine Krier; Sarah Ducrocq; Sylvie Bodard; Valérie Payen; Jean Laugier; Denis Guilloteau; Sylvie Chalon
Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia.
Neuroscience letters 2003;347(2):106-10.
2003: Sabah Aïd; Sylvie Vancassel; Carine Poumès-Ballihaut; Sylvie Chalon; Philippe Guesnet; Monique Lavialle
Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus.
Journal of lipid research 2003;44(8):1545-51.
2003: Caroline Prunier; Erwan Bézard; Jérôme Montharu; Marina Mantzarides; Jean-Claude Besnard; Jean-Louis Baulieu; Christian Gross; Denis Guilloteau; Sylvie Chalon
Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.
NeuroImage 2003;19(3):810-6.
2003: Caroline Prunier; Pierre Payoux; Denis Guilloteau; Sylvie Chalon; Bruno Giraudeau; Cynthia Majorel; Mathieu Tafani; Erwan Bezard; Jean Paul Esquerré; Jean-Louis Baulieu
Quantification of dopamine transporter by 123I-PE2I SPECT and the noninvasive Logan graphical method in Parkinson's disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):663-70.
2003: Sylvie Chalon; Jari Tarkiainen; Lucette Garreau; Håkan Hall; Patrick Emond; Johnny Vercouillie; Lars Farde; Philippe Dasse; Katarina Varnas; Jean-Claude Besnard; Christer Halldin; Denis Guilloteau
Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
The Journal of pharmacology and experimental therapeutics 2003;304(1):81-7.
2002: Johan Sandell; Meixiang Yu; Patrick Emond; Lucette Garreau; Sylvie Chalon; Kjell Någren; Denis Guilloteau; Christer Halldin
Synthesis, radiolabeling and preliminary biological evaluation of radiolabeled 5-methyl-6-nitroquipazine, a potential radioligand for the serotonin transporter.
Bioorganic & medicinal chemistry letters 2002;12(24):3611-3.
2002: Ercem Kodas; Sylvie Vancassel; Bernard Lejeune; Denis Guilloteau; Sylvie Chalon
Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage.
Journal of lipid research 2002;43(8):1209-19.
2002: Christelle Gouhier; Sylvie Chalon; Anne Aubert-Pouessel; Marie-Claire Venier-Julienne; Christophe Jollivet; Jean-Pierre Benoit; Denis Guilloteau
Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Synapse (New York, N.Y.) 2002;44(3):124-31.
2002: Luc Zimmer; Sylvie Vancassel; Sylvain Cantagrel; Patrick Breton; Séraphin Delamanche; Denis Guilloteau; Georges Durand; Sylvie Chalon
The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids.
The American journal of clinical nutrition 2002;75(4):662-7.
2002: Ercem Kodas; Guylène Page; Luc Zimmer; Sylvie Vancassel; Denis Guilloteau; Georges Durand; Sylvie Chalon
Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents.
Neuroscience letters 2002;321(1-2):95-9.
2002: Patrick Emond; Johnny Vercouillie; Robert B Innis; Sylvie Chalon; Sylvie Mavel; Yves Frangin; Christer Halldin; Jean-Claude Besnard; Denis Guilloteau
Substituted diphenyl sulfides as selective serotonin transporter ligands: synthesis and in vitro evaluation.
Journal of medicinal chemistry 2002;45(6):1253-8.
2002: Stéphanie Barc; Guylène Page; Laurence Barrier; Lucette Garreau; Denis Guilloteau; Bernard Fauconneau; Sylvie Chalon
Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.
Journal of neurochemistry 2002;80(3):365-74.
2001: Caroline Prunier; François Tranquart; Jean Philippe Cottier; B Giraudeau; Sylvie Chalon; Denis Guilloteau; B De Toffol; F Chossat; Alain Autret; Jean-Claude Besnard; Jean-Louis Baulieu
Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases.
Nuclear medicine communications 2001;22(11):1207-14.
2001: Sylvie Chalon; Sylvie Vancassel; Luc Zimmer; Denis Guilloteau; Georges Durand
Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission.
Lipids 2001;36(9):937-44.
2001: Erwan Bezard; Sandra Dovero; Caroline Prunier; Paula Ravenscroft; Sylvie Chalon; Denis Guilloteau; Alan R Crossman; Bernard Bioulac; Jonathan M Brotchie; Christian E Gross
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(17):6853-61.
2001: Sylvie Vancassel; Georges Durand; C Barthélémy; Bernard Lejeune; Joëlle Martineau; Denis Guilloteau; C Andrès; Sylvie Chalon
Plasma fatty acid levels in autistic children.
Prostaglandins, leukotrienes, and essential fatty acids 2001;65(1):1-7.
2001: Sylvain Cantagrel; Pierre Gressens; Sylvie Bodard; AL Suc; Jean Laugier; Denis Guilloteau; Sylvie Chalon
mRNA D(2) dopaminergic receptor expression after hypoxia-ischemia in rat immature brain.
Biology of the neonate 2001;80(1):68-73.
2001: Patrick Emond; Julie Helfenbein; Sylvie Chalon; Lucette Garreau; Johnny Vercouillie; Yves Frangin; Jean-Claude Besnard; Denis Guilloteau
Synthesis of tropane and nortropane analogues with phenyl substitutions as serotonin transporter ligands.
Bioorganic & medicinal chemistry 2001;9(7):1849-55.
2001: Erwan Bezard; Thomas Boraud; Sylvie Chalon; Jonathan M Brotchie; Denis Guilloteau; Christian E Gross
Pallidal border cells: an anatomical and electrophysiological study in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkey.
Neuroscience 2001;103(1):117-23.
2000: Luc Zimmer; Ercem Kodas; Denis Guilloteau; Lucette Garreau; Jean-Claude Besnard; Sylvie Chalon
Microdialysis as a tool for in vivo study of dopamine transporter function in rat brains.
Journal of neuroscience methods 2000;103(2):137-44.
2000: C Gouhier; Sylvie Chalon; Marie-Claire Venier-Julienne; Sylvie Bodard; J Benoit; Jean-Claude Besnard; Denis Guilloteau
Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide.
Neuroscience letters 2000;288(1):71-5.
2000: Luc Zimmer; S Delion-Vancassel; Georges Durand; Denis Guilloteau; Sylvie Bodard; Jean-Claude Besnard; Sylvie Chalon
Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids.
Journal of lipid research 2000;41(1):32-40.
1999: Sylvie Chalon; Lucette Garreau; Patrick Emond; Luc Zimmer; M P Vilar; Jean-Claude Besnard; Denis Guilloteau
Pharmacological characterization of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)n ortropane as a selective and potent inhibitor of the neuronal dopamine transporter.
The Journal of pharmacology and experimental therapeutics 1999;291(2):648-54.
1999: Julie Helfenbein; Johan Sandell; Christer Halldin; Sylvie Chalon; Patrick Emond; Y Okubo; Yuan-Hwa Chou; Yves Frangin; L Douziech; L Gareau; Carl-Gunnar Swahn; Jean-Claude Besnard; Lars Farde; Denis Guilloteau
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter.
Nuclear medicine and biology 1999;26(5):491-9.
1999: Sylvie Chalon; Patrick Emond; Sylvie Bodard; M P Vilar; C Thiercelin; Jean-Claude Besnard; Denis Guilloteau
Time course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease.
Synapse (New York, N.Y.) 1999;31(2):134-9.
1999: Julie Helfenbein; Christian Loc'h; Michel Bottlaender; Patrick Emond; Christine Coulon; Michèle Ottaviani; Chantal Fuseau; Sylvie Chalon; Ilonka Guenther; Jean-Claude Besnard; Yves Frangin; Denis Guilloteau; Bernard Maziere
A selective radiobrominated cocaine analogue for imaging of dopamine uptake sites: pharmacological evaluation and PET experiments.
Life sciences 1999;65(25):2715-26.
1999: Sylvie Chalon; Sylvain Cantagrel
[Monoaminergic neurotransmission and brain dysfunctions in the newborn].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1999;6 Suppl 2():197s-198s.
1998: Sylvie Chalon; S Delion-Vancassel; Catherine Belzung; Denis Guilloteau; A M Leguisquet; Jean-Claude Besnard; Georges Durand
Dietary fish oil affects monoaminergic neurotransmission and behavior in rats.
The Journal of nutrition 1998;128(12):2512-9.
1998: Guylène Page; Sylvie Chalon; Laurence Barrier; Alain Piriou; François Huguet
Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools.
Neurochemistry international 1998;33(5):459-66.
1998: Catherine Belzung; A M Leguisquet; S Barreau; S Delion-Vancassel; Sylvie Chalon; Georges Durand
Alpha-linolenic acid deficiency modifies distractibility but not anxiety and locomotion in rats during aging.
The Journal of nutrition 1998;128(9):1537-42.
1998: Patrick Emond; Lars Farde; Sylvie Chalon; Catherine Belzung; V Mauclaire; J P Chiron; Christer Halldin; Jean-Claude Besnard; Denis Guilloteau
Toxicity, mutagenicity, and behavioral effects of beta-CIT, a ligand for dopamine transporter exploration by SPECT.
Nuclear medicine and biology 1998;25(4):405-9.
1998: Denis Guilloteau; Patrick Emond; Jean-Louis Baulieu; Lucette Garreau; Yves Frangin; Léandre Pourcelot; L Mauclaire; Jean-Claude Besnard; Sylvie Chalon
Exploration of the dopamine transporter: in vitro and in vivo characterization of a high-affinity and high-specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-m ethylph enyl)nortropane (PE2I).
Nuclear medicine and biology 1998;25(4):331-7.
1998: Jyrki T Kuikka; Jean-Louis Baulieu; Jukka Hiltunen; Christer Halldin; Kim A Bergström; Lars Farde; Patrick Emond; Sylvie Chalon; M Yu; T Nikula; T Laitinen; Jari Karhu; Erkki Tupala; Tero Hallikainen; V Kolehmainen; L Mauclaire; Bernard Maziere; Jari Tiihonen; Denis Guilloteau
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging.
European journal of nuclear medicine 1998;25(5):531-4.
1998: S Favrelière; Laurence Barrier; G Durand; Sylvie Chalon; Claude Tallineau
Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum.
Lipids 1998;33(4):401-7.
1998: Luc Zimmer; S Hembert; Georges Durand; Patrick Breton; Denis Guilloteau; Jean-Claude Besnard; Sylvie Chalon
Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study.
Neuroscience letters 1998;240(3):177-81.
1998: François Huguet; A Guerraoui; Laurence Barrier; Denis Guilloteau; Claude Tallineau; Sylvie Chalon
Changes in excitatory amino acid levels and tissue energy metabolites of neonate rat brain after hypoxia and hypoxia-ischemia.
Neuroscience letters 1998;240(2):102-6.
1997: Lucette Garreau; Patrick Emond; Catherine Belzung; Denis Guilloteau; Yves Frangin; Jean-Claude Besnard; Sylvie Chalon
N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain.
The Journal of pharmacology and experimental therapeutics 1997;282(1):467-74.
1997: Patrick Emond; Sylvie Chalon; Lucette Garreau; A M Dognon; Sylvie Bodard; Yves Frangin; Jean-Louis Baulieu; Jean-Claude Besnard; Denis Guilloteau
A new iodinated tropane derivative (beta-CDIT) for in vivo dopamine transporter exploration: comparison with beta-CIT.
Synapse (New York, N.Y.) 1997;26(1):72-80.
1997: Patrick Emond; Lucette Garreau; Sylvie Chalon; M Boazi; M Caillet; J Bricard; Yves Frangin; L Mauclaire; Jean-Claude Besnard; Denis Guilloteau
Synthesis and ligand binding of nortropane derivatives: N-substituted 2beta-carbomethoxy-3beta-(4'-iodophenyl)nortropane and N-(3-iodoprop-(2E)-enyl)-2beta-carbomethoxy-3beta-(3',4'-disubstituted phenyl)nortropane. New high-affinity and selective compounds for the dopamine transporter.
Journal of medicinal chemistry 1997;40(9):1366-72.
1997: S Delion; Sylvie Chalon; Denis Guilloteau; B Lejeune; Jean-Claude Besnard; Georges Durand
Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet.
Journal of lipid research 1997;38(4):680-9.
1996: Sylvie Chalon; christian pellevoisin; Sylvie Bodard; M P Vilar; Jean-Claude Besnard; Denis Guilloteau
Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain.
Synapse (New York, N.Y.) 1996;24(4):334-9.
1996: christian pellevoisin; Denis Guilloteau; Jean-Louis Baulieu; Christian Loc'h; A M Dognon; L Mauclaire; J C Saccavini; Jean-Claude Besnard; Sylvie Chalon
Iodolisuride and iodobenzamide, two ligands for SPECT exploration of the dopaminergic D2 receptors: a comparative study.
Synapse (New York, N.Y.) 1996;24(1):79-86.
1996: S Delion; Sylvie Chalon; Denis Guilloteau; Jean-Claude Besnard; Georges Durand
alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex.
Journal of neurochemistry 1996;66(4):1582-91.
1996: christian pellevoisin; Sylvie Chalon; H F Kung; Jean-Claude Besnard; Denis Guilloteau
Is TISCH a suitable tracer for in vivo study of modifications of the dopamine D-1 receptor?
Nuclear medicine and biology 1996;23(1):75-8.
1996: H Rafii; Sylvie Chalon; J E Ombetta; Yves Frangin; L Pourcelot; Jean-Claude Besnard; Sylvie Bodard; Denis Guilloteau
An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration.
Life sciences 1996;58(14):1159-69.
1995: I Lena; J E Ombetta; Sylvie Chalon; A M Dognon; Jean-Louis Baulieu; Yves Frangin; Lucette Garreau; Jean-Claude Besnard; Denis Guilloteau
Iododerivative of pargyline: a potential tracer for the exploration of monoamine oxidase sites by SPECT.
Nuclear medicine and biology 1995;22(6):727-36.
1995: H Rafii; Sylvie Chalon; J E Ombetta; Yves Frangin; Lucette Garreau; A M Dognon; I Lena; Sylvie Bodard; M P Vilar; Jean-Claude Besnard
Synthesis and characterization of [125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitor.
Nuclear medicine and biology 1995;22(5):617-23.
1995: C Branger; Lucette Garreau; A M Dognon; Yves Frangin; M Caillet; J E Ombetta-Goka; Sylvie Chalon; Jean-Claude Besnard; Denis Guilloteau
Synthesis of 4'-iodo-5-methoxy-valerophenone O-(2-aminoethyl)oxime as an agent for exploration of serotoninergic transporter.
Nuclear medicine and biology 1995;22(2):157-64.
1994: S Delion; Sylvie Chalon; J Hérault; Denis Guilloteau; Jean-Claude Besnard; Georges Durand
Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats.
The Journal of nutrition 1994;124(12):2466-76.
1994: A Zouakia; Sylvie Chalon; H F Kung; A M Dognon; E Saliba; Jean-Claude Besnard; Denis Guilloteau
Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury.
European journal of nuclear medicine 1994;21(6):488-92.
1993: christian pellevoisin; Sylvie Chalon; A Zouakia; A M Dognon; Yves Frangin; Jean-Louis Baulieu; Jean-Claude Besnard; Denis Guilloteau
Comparison of two radioiodinated ligands of dopamine D2 receptors in animal models: iodobenzamide and iodoethylspiperone.
Life sciences 1993;52(23):1851-60.
1992: C Foulon; Lucette Garreau; Sylvie Chalon; G Desplanches; Yves Frangin; Jean-Claude Besnard; Jean-Louis Baulieu; Denis Guilloteau
Synthesis and in vitro binding properties of halogenated analogues of GBR as new dopamine uptake carrier ligands.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(5):597-600.
1990: Sylvie Chalon; C Guimbal; Denis Guilloteau; W Mayo; François Huguet; M H Schmitt; G Desplanches; Jean-Louis Baulieu; Jean-Claude Besnard
Iodobenzamide for in vivo exploration of central dopamine receptors: evaluation in animal models of supersensitivity.
Life sciences 1990;47(8):729-34.
1990: Jean-Louis Baulieu; François Huguet; Sylvie Chalon; P Gerard; Yves Frangin; Jean-Claude Besnard; L Pourcelot; Denis Guilloteau
[125I]MIBG uptake and release in different regions of the rat brain.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(5):511-4.
1990: Sylvie Chalon; Yves Frangin; Denis Guilloteau; M Caillet; C Guimbal; M H Schmitt; G Desplanches; Jean-Louis Baulieu; Jean-Claude Besnard
Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1990;17(4):389-95.
1988: Denis Guilloteau; François Huguet; Sylvie Chalon; Jean-Louis Baulieu; P Gerard; G Narcisse; L Pourcelot; Jean-Claude Besnard
MIBG and catecholamine storage in the brain: an in-vitro study.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(6):723-4.
1988: Denis Guilloteau; Sylvie Chalon; Jean-Louis Baulieu; François Huguet; G Desplanches; C Chambon; M P Vilar; L Pourcelot; Jean-Claude Besnard
Comparison of MIBG and monoamines uptake mechanisms: pharmacological animal and blood platelets studies.
European journal of nuclear medicine 1988;14(7-8):341-4.